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Lysophosphatidic acid (LPA) is an extracellular lipid mediator that regulates nervous
system development and functions acting through G protein-coupled receptors
(GPCRs). Here we explore the crosstalk between LPA1 receptor and glutamatergic
transmission by examining expression of glutaminase (GA) isoforms in different
brain areas isolated from wild-type (WT) and KOLPA1 mice. Silencing of LPA1
receptor induced a severe down-regulation of Gls-encoded long glutaminase protein
variant (KGA) (glutaminase gene encoding the kidney-type isoforms, GLS) protein
expression in several brain regions, particularly in brain cortex and hippocampus.
Immunohistochemical assessment of protein levels for the second type of glutaminase
(GA) isoform, glutaminase gene encoding the liver-type isoforms (GLS2), did not
detect substantial differences with regard to WT animals. The regional mRNA
levels of GLS were determined by real time RT-PCR and did not show significant
variations, except for prefrontal and motor cortex values which clearly diminished
in KO mice. Total GA activity was also significantly reduced in prefrontal and motor
cortex, but remained essentially unchanged in the hippocampus and rest of brain
regions examined, suggesting activation of genetic compensatory mechanisms
and/or post-translational modifications to compensate for KGA protein deficit.
Remarkably, Golgi staining of hippocampal regions showed an altered morphology
Abbreviations: DAB, diaminobenzidine tetrahydrochloride; GA, glutaminase; GAB, Gls2-encoded long glutaminase protein
variant; GAC, Gls-encoded short glutaminase protein variant; Gls, glutaminase gene encoding the kidney-type isoforms;
Gls2, glutaminase gene encoding the liver-type isoforms; KGA, Gls-encoded long glutaminase protein variant; LGA,
Gls2-encoded short glutaminase protein variant; LPA, lysophosphatidic acid; LPARs, lysophosphatidic acid receptors; LTP,
long-term potentiation; MMP, matrix metalloproteinase; NMDA, N-methyl-D-aspartate; NPCs, neural progenitor cells;
NP-40, Nonidet-P40; PBS, phosphate-buffered saline; PFC, prefrontal cortex; PSD95, post-synaptic density protein 95;
ROCK, Rho kinase; TBS, Tris-buffered saline; TCA, trichloroacetic acid; tPA, tissue plasminogen activator.
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of glutamatergic pyramidal cells dendritic spines towards a less mature filopodia-like
phenotype, as compared with WT littermates. This structural change correlated with
a strong decrease of active matrix-metalloproteinase (MMP) 9 in cerebral cortex and
hippocampus of KOLPA1 mice. Taken together, these results demonstrate that LPA
signaling through LPA1 influence expression of the main isoenzyme of glutamate
biosynthesis with strong repercussions on dendritic spines maturation, which may
partially explain the cognitive and learning defects previously reported for this colony
of KOLPA1 mice.
Keywords: lysophosphatidic acid, glutaminase, glutamate, matrix metalloproteinases, rodent knockout model,
synaptic plasticity
INTRODUCTION
Lysophosphatidic acid (LPA; 1 or 2-acyl-sn-glycero-3-
phosphate) is a naturally occurring lysophospholipid derived
from cell membranes that belongs to the growing list of
bioactive lipids. It may act as an intercellular signaling molecule
after recognition by G protein-coupled receptor(s) (GPCRs).
In mammals, LPA is enriched in brain tissue, produced by
platelets and cells from the nervous system and is also found
in serum (Choi and Chun, 2013; Yung et al., 2015). Six types
of LPA receptors (LPARs) have been identified so far named
LPA1-LPA6, with different expression patterns and involved in
different functions (Chun et al., 2010; Mutoh et al., 2012; Yung
et al., 2014).
Multiple cellular responses have been reported for this
bioactive natural lipid in the central nervous system (CNS)
as well as in neural cell lines. LPA elicited sharp changes in
cell’s shape and morphology, growth cone collapse and neurite
retraction in many neuronal cell lines through activation of
the small GTPase Rho which in turn contracts cytoskeleton
(Ye et al., 2002; Choi et al., 2010; Fukushima et al., 2011).
Furthermore, LPA also affect cell motility in glioma cell lines
through Rho/Rho-associated kinases (ROKC) signaling cascades,
which may contribute to their invasive phenotype in vivo
(Manning et al., 2000). In cultured astrocytes, LPA induces a
plethora of responses including proliferation and inhibition of
glutamate uptake (Steiner et al., 2002; Shano et al., 2008). Of
note, LPA-primed astrocytes promote neuronal differentiation
of cerebral cortical progenitors and developing cortical neurons,
which showed increases in arborization and neurite outgrowth
(Spohr et al., 2008, 2011).
Although many types of LPARs have been detected in
brain, LPA1 is abundantly expressed and considered the most
prevalent receptor type in both embryonic and adult brains
of humans and mice (Hecht et al., 1996; Choi et al., 2010;
Mutoh et al., 2012). Genetic silencing of LPA1 in mice causes
a reduced ventricular zone along with loss of cortical layer
cellularity (Estivill-Torrús et al., 2008), reduces neurogenesis
in the dentate gyrus (DG; Matas-Rico et al., 2008), and
shows altered neurotransmitter homeostasis (Musazzi et al.,
2011; Blanco et al., 2012a) which were previously related to
psychiatric diseases (Harrison et al., 2003; Roberts et al., 2005).
Behavioral studies with LPA1 deficientmice reported deficiencies
in spatial memory retention and abnormal use of searching
orientation strategies (Santin et al., 2009), defective working and
reference memory independently of exploratory and emotional
impairments attributed to hippocampal malfunction (Castilla-
Ortega et al., 2010). Lastly, mice lacking LPA1 receptor exhibit an
endophenotype for alcohol preference associated with glutamate
receptor alterations in the prefrontal cortex (PFC), including
a decrease in their relative mRNA levels of Gls-encoded long
glutaminase protein variant (KGA; Castilla-Ortega et al., 2016).
Studies dealing with KO models of LPARs are giving new
insights into the role of LPA in developmental and differentiation
processes of neurons and glial cells and their cross-talk in the
tripartite synapsis; however, little is known about how LPA
signaling regulates synaptic function and neurotransmission
(Ye et al., 2002; García-Morales et al., 2015). LPA may
modify N-methyl-D-aspartate (NMDA) receptor functions in
hippocampal neurons (Lu et al., 1999) as well as calcium
intracellular levels (Holtsberg et al., 1997). Furthermore, LPA
inhibited Na+, K+-ATPase activity in rat cortical synaptosomes
(Nishikawa et al., 1989) and was related with synaptic vesicle
formation (Schmidt et al., 1999). In addition, LPA through
LPA1 receptor has been proposed as a potential candidate
to control short-term synaptic plasticity both in excitatory
and inhibitory synapses, but using different mechanisms:
decreasing the synaptic vesicle pool and reducing the number
of postsynaptic receptors, respectively (García-Morales et al.,
2015). The aim of this study was to elucidate further relationships
between LPA signaling and synaptic plasticity of glutamatergic
excitatory transmission using KOLPA1 mice as a model.
We found marked regional down-regulations of the main
glutaminase (GA; EC 3.5.1.2) isoform (KGA) involved in
the synthesis of neurotransmitter glutamate, altered dendritic
spines morphology at the glutamatergic pyramidal cells of the
hippocampus and a decrease in MMP-9 activity and expression,
an enzyme crucially required for dendritic spine maturation
and remodeling. Altogether, the results point to important
implications of LPA in synaptic excitatory plasticity which may




The generation and characterization of maLPA1-null mice
has been described previously (Estivill-Torrús et al., 2008).
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An LPA1-null mouse colony, termed maLPA1 after the Málaga
variant of the LPA1 knockout, was spontaneously derived during
the original colony (Contos et al., 2000) expansion by crossing
heterozygous (HT) foundation parents (maintained in the
original hybrid C57BL/6J6x1291/SvJ background). Intercrosses
were performed with these mice and were subsequently
backcrossed for 20 generations with mice generated within
this mixed background. MaLPA1-null mice carrying the LPA1
deletion were born at the expected Mendelian ratio and
survived to adulthood. Targeted disruption of the Lpa1 gene
was confirmed by genotyping (Contos et al., 2000), and
immunochemistry confirmed the absence of LPA1 protein
expression. Three month-old male littermates from wild-type
(WT), heterozygous and malLPA1-null homozygous (KOLPA1)
genotypes were employed for immunohistochemistry. In all
other experiments, WT and KOLPA1 genotypes were employed.
Mice were singly housed on a 12-h light/dark cycle (lights
on at 07:00 a.m.). Water and food were provided ad libitum.
All animal experiments were performed in accordance with
the animal research regulations (RD53/2013 and 2010/63/UE)
from Spain and European Union, and with the approval of the




For immunohistochemical studies animals (n = 8 mice per
genotype) were deeply anesthetized with sodium pentobarbital
(60 mg/kg) and perfused transcardially with 0.1 M phosphate
buffer (PB) saline (PBS), pH 7.4, followed by fixative solution
(4% paraformaldehyde, 75 mM lysine and 10 mM sodium
metaperiodate in 0.1 M PB, pH 7.4). After overnight postfixation
in the same fixative at 4◦C, brains were cryoprotected (30%
sucrose), sectioned (40µm) on a freezing microtome and serially
collected (six series for each brain, with a separation of 240
µm between consecutive sections) in wells containing cold
PBS and 0.02% sodim azide. The rabbit polyclonal isoform-
specific antibodies anti-KGA and anti-GAB (glutaminase gene
encoding the liver-type isoforms (Gls2)-encoded long GA
isoform) were generated and characterized in our laboratory
(Olalla et al., 2002, 2008; Campos et al., 2003; Cardona
et al., 2015). Briefly, free-floating sections, after blocking
the endogenous peroxidase activity (3% H2O2/10% methanol
in 0.1 M PBS pH 7.4 for 20 min) and avidin, biotin,
and biotin-binding proteins for 30 min with avidin-biotin
blocking Kit (Vector Labs, United Kingdom), were incubated
with the affinity-purified rabbit polyclonal anti-KGA antibody
(1:1000) or rabbit polyclonal anti-GAB antibody (1:500 dilution)
for 48 h at room temperature. The tissue-bound primary
antibody was then detected by incubating with biotinylated
anti-rabbit IgG (Vector Labs, United Kingdom) for 1 h at
room temperature (1:500 dilution) and then with ExtrAvidin-
peroxidase conjugate (Sigma-Aldrich, Spain) for 1 h at room
temperature (1:2000 dilution). Immunoreaction product was
visualized with 0.05% 3-3′-diaminobenzidine tetrahydrochloride
(DAB; Sigma-Aldrich, Spain), 0.03% nickel ammonium sulfate,
and 0.01% H2O2 in PBS. Sections were then mounted onto
gelatin-coated slides, dehydrated in graded ethanol, cleared
in xylene and coverslipped with DPX mounting medium
(VWR BDH Prolabo, VWR International). Immunostaining was
observed under a Nikon Eclipse 80i microscope and images
acquired with a Nikon DS-5M high-resolution digital camera. All
immunohistochemical studies by light microscopy were tested
using negative controls (omitting the primary antisera) and no
immunoreaction products were detected in any case.
Golgi Staining
Golgi staining with FD Rapid GolgiStainTM kit (Golgi-Cox
technique; FD Neurotechnologies) was performed to detect
morphological alterations in neuronal dendrites and dendritic
spines. The kit was used following the provider instructions.
Briefly, adult male mice from both genotypes, WT and KOLPA1
(n = 5 per group), were deeply anesthetized with sodium
pentobarbital (60 mg/kg) and brains were immediately removed.
Tissues were rinsed in distilled water and immersed in the
fixative solution (A + B) during 2 weeks in the dark. Afterwards,
brains were transferred to solution C for 4 days. Before sectioning
on a freezing microtome (Leica, CM 1325), tissue was rapidly
frozen in isopentane precooled to −70◦C. Sections of 150 µm
were mounted with solution C on gelatine-coated slides and
air-dried at RT. Then, the kit staining procedure was followed,
and slides were dehydrated in graded ethanol, cleared in xylene
and coverslipped with DPX (BDH) mounting medium.
Microphotographs of basal pyramidal dendrites in
CA1 stratum oriens from hippocampus were acquired using a
63× oil-immersion objective of a SP5 II microscope (Leica) with
a 405 Diode, UV Laser. Series of Z-stacks of dendrites were taken
with 0.3 µm spacing. LAS AF Lite (Leica) software was used
for quantification and morphometric analysis. For quantitative
analysis, we assessed nonprimary dendritic segments, using
the following criteria: (1) the quality of Golgi staining; (2) the
relative isolation of the dendrites; (3) we selected only the
spines that protruded in the transverse direction and were
clearly distinguished. Spine density (number of spines per
10 µm), as well as dendrite diameter at several points of each
counted segment, were measured. Other parameters such as
spine morphology and length were also evaluated. Protrusions
from dendrites were classified based on predefined parameters as
mushroom spines, stubby spines, thin spines, or filopodia (Ghani
et al., 2017). A total of 527 dendritic spines (283 spines for WT
and 244 for KOLPA1 mice) were analyzed. Finally, mushroom
head size was assessed, defining the head width (µm) as the
diameter of the largest spine section that was perpendicular to a
virtual axis of the spine trajectory (Ruszczycki et al., 2012).
Real-Time Quantitative RT-PCR
For qRT-PCR analyses (and enzymatic assays), animals were
sacrificed by decapitation. Brains were quickly removed,
frozen (−80◦C) and dissected in coronal brain slices (2 mm
thickness) with razor blades in a mouse brain slicer matrix
(Zivic Instruments). The discrete brain regions (striatum,
hippocampus, PFC and cerebellum) were picked up by free
hand dissection using a scalpel. These brain regions were
identified according to Mouse Brain in Stereotaxic Coordinates
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(Paxinos and Franklin, 2001) as described previously (Blanco
et al., 2012a): striatum from the Bregma 1.54 mm to −0.46 mm,
hippocampus from the Bregma −1.22 mm to −3.52 mm, PFC
from the Bregma 2.46 mm to 1.34 mm and cerebellum from the
Bregma−5.52 mm to−7.80 mm.
Total RNA from brain regions was isolated according to
manufacturer’s specifications (AllPrep DNA/RNA/Protein Mini
Kit, Qiagen). Total RNA (1 µg) were reverse transcribed using
the Quantitec Reverse Transcription kit (Qiagen) in a 20 µl
reaction, according to manufacturer’s instructions. RNA samples
were tested for genomic DNA contamination by including
reverse transcriptase (RT) omitted controls, and for reagents and
aerosol contamination by including two non-template controls.
Real time PCR was carried out with the CFX thermocycler (Bio-
Rad) as described elsewhere (Martín-Rufián et al., 2012). GLS
transcripts were amplified using mouse GLS-specific primers:
GLS forward (5′-GCGAGGGCAAGGAGATGGTG-3′) and GLS
reverse (5′-CTCTTTCAACCTGGGATCAGA TGTTC-3′), as
described previously (Martín-Rufián et al., 2012). Results were
evaluated using CFX Bio-Rad Analysis Software. Amplicon size
and the absence of non-specific products were confirmed by
agarose gel electrophoresis. For absolute quantification of GA
transcripts, PCR transcript-specific amplicons were prepared
as standards. PCR products were analyzed by 2% agarose gel
electrophoresis and purified (IllustraTM GFXTMPCR DNA and
Gel Band Purification Kit, GE Healthcare). The standard curve
was created by plotting the threshold cycle (Ct) corresponding
to each standard, vs. the value of their corresponding log of
starting quantity (DNA copy number). GLS transcripts were
expressed as numbers of molecules (± SEM) of mRNA per ng
of total RNA. Five animals of each genotype (WT and KOLPA1)
were employed and independent experiments were performed in
triplicate.
Glutaminase Activity Assay
Brain regions were isolated as described above. The discrete
brain regions from dissections were resuspended in TES buffer
(25 mM Tris–HCl, 0.2 mM EDTA, 0.33 M sucrose, pH 8.0)
containing the complete protease inhibitor cocktail (Roche),
homogenized with a Pestle motor mixer (VWR) and solubilized
with TX-100 at a final concentration of 1% (v/v) for 1 h
at 4◦C. After centrifugation at 100,000× g for 30 min at
4◦C, the supernatants were divided into aliquots and kept at
−80◦C until analysis. The protein content in each sample was
determined by the Bradford method. GA activity was assayed
by measuring the ammonia produced in the catalytic reaction
as described by Heini et al. (1987). Briefly, samples of 25 µL
were added to 35 µL of a mixture of 100 mM potassium
phosphate, 171 mM L-Gln and 1.5 mM NH4Cl, pH 8.0 and
incubated for 1 h at 37◦C. The reaction was terminated by adding
10 µL of trichloroacetic acid (TCA) 10% (w/v), kept on ice for
15 min and centrifuged at 12,000× g. Aliquots of 5 µL were
then mixed with 150 µL of o-phthalaldehyde/mercaptoethanol
reagent (10 mL 0.2 M potassium phosphate, pH 7.4, 0.56 mL
of 72 mM mercaptoethanol in ethanol and 0.56 mL of 186 mM
o-phthalaldehyde in ethanol). The samples were kept at room
temperature in the dark and their absorbance measured at
410 nm after 45 min together with an NH4Cl standard. For
blanks, the samples and substrate solution were incubated
separately and mixed after the addition of TCA.
Gel Zymography of MMP-9 and MMP-2
Activity
Brain regions were homogenized in nonyl
phenoxypolyethoxylethanol (NP-40, Thermo Fisher) lysis
buffer (150 mM NaCl, 50 mM Tris-HCl, 1% NP-40, pH 7.4)
supplemented by 5% protease inhibitor cocktail (Sigma-Aldrich,
Spain) and 1% phosphatase inhibitor cocktail-2 (Sigma-Aldrich,
Spain). Protein concentrations were measured by DC Protein
Assay kit (Bio-Rad, Spain). Samples (20 µg of total protein)
were mixed with 4× non reducing loading buffer, heated 15 min
at 37◦C and subjected to 9% SDS-PAGE gel with 0.1% gelatin
(w/v) (Sigma, Spain). Gels were washed twice for 30 min at room
temperature with slight shaking in enzymatic activation buffer
(50 mM Tris-HCl, 6 mM CaCl2, 1.5 µM ZnCl2, pH 7.4) with
2.5% Tween-20 to remove SDS and restore gelatinase activity.
Gels were then incubated at 37◦C for 48 h in enzymatic activation
buffer without Tween-20. Gels were stained in Coomasie brilliant
blue (Bio-Rad, Spain) until gels were dark blue colored, followed
by immersion in discoloring solution (40% methanol, 10% acetic
acid) until bands were clear. Gels were digitized and bands were
quantified by ImageJ Software version 1.42q (NIH, Bethesda,
MD, USA).
Gel Zymography of Tissue Plasminogen
Activator (tPA) Activity
Tissue plasminogen activator (tPA) was measured because of its
role on MPP-9 proteolytic activation. tPA activity was assessed
in the same samples mentioned above. Samples were mixed
with 4× non reducing loading buffer, heated 15 min at 37◦C
and subjected to 9% SDS-PAGE gel with 0.1% plasminogen
(Millipore, Spain) and 0.1% casein (Sigma-Aldrich, Spain). Gels
were washed twice for 30 min at room temperature with slight
shaking in modified enzymatic activation buffer (0.1 M Tris-
HCl, 0.1 M glycine, 0.01 M EDTA, pH 8.0) with 2.5% Tween-20
to remove SDS and restore gelatinase activity. Gels were then
incubated at 37◦C for 48 h in modified enzymatic activation
buffer without Tween-20. tPA activity bands were developed and
quantified in the same way that we mentioned above.
Western Blotting
To measure levels of GA and MMP-9 proteins in each
brain region, Western blotting was performed with purified
specific polyclonal antibodies against KGA and GAB, as well
as commercial antibodies against MMP-9 (Millipore, Spain
AB19016, 1/1000). Protein samples (40 µg for KGA and GAB
or 20 µg for MMP-9 detection) were separated on SDS-PAGE
gels and transferred to nitrocellulose or PVDF membranes.
After blocking at room temperature for 1 h with 5% bovine
serum albumin (BSA) in TBST buffer (0.1% Tween 20 in
Tris-buffered saline, TBS, 100 mM Tris, 150 mM NaCl, pH 7.5),
membranes were incubated with primary antibodies in blocking
buffer with 5% BSA, overnight at 4◦C. After incubation with
secondary antibody, the blots were developed by enhanced
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FIGURE 1 | Comparative analysis of immunostaining for Gls-encoded long glutaminase protein variant (KGA) in wild-type (WT), heterozygous (HT) and KOLPA1 mice
brain. Specific immunolabeling for KGA was detected within the somata/neuropile of several brain regions in WT brain (left column). In general, there was a strong
reduction in the staining together with a progressive switch to a perivascular location from control to HT and KO mice (A–C), panoramic views of sections containing
cerebral cortex and striatum, black arrows indicate KGA-positive blood vessels). (D–F) Progressive change of KGA-staining in deep layers of agranular insular cortex
(square; detail of cortical somatic staining, inset in (D); detail of blood vessel, inset in E). (G–I) KGA-positive staining in the CA1-CA3 hippocampal subfields and DG
was dramatically decreased in both HT and KO genotypes in comparison to WT. (J–L) DG and slm neuropile stainings were found to be very affected in HT (K1) and
(Continued)
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FIGURE 1 | Continued
KOLPA1 (L1) mice in comparison to WT (J1), as well as CA3 principal
neurons (J2–L2), and to a lesser extent equivalent CA1 neurons (J3–L3).
(M–O) Ventrally, in the hypothalamic levels, we found good examples of this
gradual change to perivascular staining around the 3V. No differences were
detected among the different genotypes in cerebellum (P–R). Ctx, cortex;
St, striatum; bv, blood vessel; CA1, CA3, hippocampal subfields; DG, dentate
gyrus; Th, thalamus; so, stratum oriens; sp, stratum pyramidale; sr, stratum
radiatum; slm, stratum lacunosum-moleculare; m, molecular layer; mo, outer
molecular layer; mi, inner molecular layer; h, hilus; g, granular layer; Pe,
periventricular hypothalamic nucleus; 3V, third ventricle; G, cerebelar granular
layer; M, cerebelar molecular layer. Scale bar: A–C, 1 mm; D–F, 100 µm; G–I,
500 µm; J1–L1, 50 µm; J2–L2 and J3–L3, 20 µm; M–R, 200 µm; inset: D,
25 µm; inset: E, 40 µm.
chemiluminescense technique as recommended by the supplier
(Pierce) and bands quantified using the Chemi Doc System
(BioRad). β-actin was quantified and used as a loading control.
Statistics
All statistical analyses were conducted using two-tailed unpaired
t-tests (WT vs. KOLPA1) except when the assumptions
of normality and/or homoscedasticicity were violated (Golgi
staining). In the latter case, non-parametric Mann-Whitney tests
were carried out to compare WT and KOLPA1 genotypes. The
significance level was set at 5%. GraphPad Prism 7 software
(La Jolla, CA, USA) was used to perform all statistical analyses.
RESULTS
Silencing of LPA1 Sharply Decreases KGA,
but Not GLS2, Protein Expression
Four different GA isoenzymes are expressed in mammalian
brain (Márquez et al., 2016): KGA and Gls-encoded short
glutaminase protein variant (GAC) proteins are encoded by
the Gls gene (GLS isoforms), whilst GAB and Gls2-encoded
short glutaminase protein variant (LGA) arise from the
Gls2 gene (GLS2 isoforms; Aledo et al., 2000; Matés et al.,
2013). The influence of silencing LPA1 receptor on brain
GA protein expression was assessed by immunohistochemistry
of the KGA and GLS2 (GAB/LGA) isoforms. The isoform-
specific anti-KGA antibodies employed were raised for a unique
C-terminal region of this isoform, which is absent in the
GAC isoform, and hence they cannot recognize this second
GLS isoform (GAC); however, GAB antibodies would recognize
both GLS2 isoforms (GAB and LGA). The immunostaining
obtained for KGA (Figure 1) revealed a cytoplasmic punctate
pattern typical for a mitochondrial localization, in accordance
with previous reports on KGA localization in mammalian
brain (Olalla et al., 2002; Cardona et al., 2015). However, a
drastic decrease in the intensity of the staining was clearly
seen in several cerebral regions from HT and KO mice, like
cortex (Figures 1B,C, details in Figures 1E,F, respectively) and
hippocampus (Figures 1H,I, respectively) in comparison to the
same areas in WT mice (Figures 1A,D,G). Specifically, in the
hippocampus, CA3 pyramidal layer neurons (Figures 1J3–L3)
and the neuropile of both CA1 stratum lacunosum-moleculare
and DG molecular layer (Figures 1J1–L1) were among the
most affected. In addition, neuronal KGA-immunolabeling in
certain cortical regions, like deep layers of agranular insular
cortex (Figures 1D–F), was also notably reduced, whereas in
others, as the cerebellum, non-specific alteration was observed
(Figures 1P–R). Interestingly, these reductions in the KGA
labeling were generally gradual from control to HT and KO
animals, which seem to reflect a proportional decline on KGA
protein expression when LPA1 receptor levels were diminished.
Also progressive was the appearance of intense perivascular
immunoreactivity in animals with decreased LPA1 expression,
especially in the KO mice (Figures 1C,F,M–O).
In contrast with KGA, the immunolabeling patterns against
GLS2 isoforms were roughly similar for the three types of
mouse strains studied (Figure 2). No apparent change on
GLS2 expression was found in the different brain regions
analyzed by immunohistochemistry such as brain cortex,
striatum (Figures 2A–C), hippocampus (Figures 2D–F) or
cerebellum (Figures 2G–I). As expected, the appearance of the
immunolabeling revealed a distinct pattern compared with KGA,
showing a broad nuclear staining characteristic of GLS2 in
mammalian brain (insets in Figure 2), in agreement with
previously reported data (Olalla et al., 2002; Cardona et al.,
2015). Finally, supporting experimental evidences were obtained
by immunoblot analysis of total protein extracts isolated from
whole cerebral cortex and hippocampus and revealed with
isoform-specific KGA antibodies (Figure 3). In agreement with
immunohistochemical data revealing a decreased KGA protein
expression, Western blot results also showed a significant
reduction of KGA protein in both regions (Figure 3). Meanwhile,
GLS2 protein levels were not significantly altered in cerebral
cortex and hippocampus as assessed by immunoblot assays
(results not shown).
Enzymatic Activity and GLS mRNA Levels
in KOLPA1 Mice
The results of real-time PCR indicate that mRNA levels of GLS
(KGA + GAC) remained essentially unchanged in KOLPA1
mice, with the exception of prefrontal and motor cortex where
a significant decrease was observed (Figure 4; see also Castilla-
Ortega et al., 2016). With regard to GA activity, we assayed
enzyme catalytic activity in total protein extracts isolated from
individual brain areas. The GA activity measured in whole
regions from WT and KOLPA1 mice did not show significant
variations, except for the motor cortex and PFC of LPA1-
deficient mice which showed a significant bias to lower activity
levels (Figure 5). Altogether, the results suggest a lack of
correlation between GLS mRNA levels and protein/activity
values in most cerebral regions studied, except for two cerebral
cortex subregions: motor and PFC, where diminished mRNA
levels correlated with reduced KGA protein and GA activity
values.
Anomalous Dendritic Spine Morphology in
KOLPA1 in Mice
The potential involvement of LPA signaling in developmental
process and neurotransmitter handling has been previously
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FIGURE 2 | Immunohistochemal staining for glutaminase gene encoding the liver-type isoforms (GLS2) in WT, HT and KOLPA1 mice brain. Immunolabeling for
GLS2 isoforms yielded a nuclear staining in all the brain regions analyzed by this technique. (A–C) Cerebral cortex and insets showing details from layer III of the
motor cortex (white squares). (D–F) Hippocampus and details from CA1 stratum pyramidale in insets. (G–I) Details from cerebellum are depicted. No differences
were detected among the different genotypes in any of these cerebral areas. Ctx, cortex; St, striatum; CA1, CA3, hippocampal subfields; sp, stratum pyramidale;
DG, dentate gyrus; Th, thalamus; G, cerebelar granular layer; P, Purkinje layer; M, cerebelar molecular layer. Scale bar: A–C: 500 µm, D–F: 250 µm, G–I: 100 µm;
Insets: 20 µm.
reported. Glutamate has been also involved in trophic
functions and neuronal development. Therefore, we wanted
to check whether the absence of LPA1 receptor and/or the
strong deficit observed in GLS protein expression would
affect the dendritic spines. Since hippocampus exhibited a
pronounced KGA deficit and the behavioral phenotype of the
LPA1 deficient mice are mainly attributed to hippocampal
malfunction (Santin et al., 2009; Castilla-Ortega et al., 2010;
Blanco et al., 2012a), we decided to assess dendritic spine
density and morphology using the Golgi-Cox staining in
the CA1 region. Representative images of basal pyramidal
dendrites in CA1 are shown in Figure 6A (WT) and
Figure 6B (KOLPA1). First, we quantified the spine density
(number of spines per 10-µm long dendritic segments) in
nonprimary dendrites. Although we did not find statistically
significant differences (not shown) neither in spine density
nor dendrite diameter (Mann-Whitney, p = 0.12 and p = 0.86,
respectively), between KOLPA1 and WT mice, microscopic
analysis revealed morphological alterations in the KO
dendritic spines. Subsequently, we performed a detailed
morphometric analysis of CA1 pyramidal dendrites, and first
observed that dendritic spines from this region were longer,
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FIGURE 3 | Immunoblot analysis of KGA protein expression in cerebral cortex
and hippocampus. Total protein extracts (40 µg) were isolated from cerebral
cortex and hippocampus of WT and KOLPA1 mice and analyzed by Western
blotting using isoform-specific KGA antibodies. A representative Western blot
is shown in the top panel, using β-actin as a loading control. Densitometry
analysis of the blots was done using the Chemi Doc System (Bio-Rad). KGA
expression values normalized to β-actin are shown in the bottom panel. Values
are means ± SEM of nine animals of each phenotype (WT and KOLPA1).
∗∗∗p < 0.001; ∗∗p < 0.01.
tortuous and thinner in KO (Figures 6F–H) than in WT
mice (Figures 6C–E), exhibiting the typical characteristics
of immature states (Ebrahimi and Okabe, 2014). Overall
FIGURE 4 | Quantitative measurement of GLS mRNA levels by real-time
RT-PCR. Total RNA was isolated from the different brain regions and absolute
quantifications of GLS mRNA levels were performed as described in the
Methods section. Five animals of each genotype were analyzed. The GLS
transcripts are expressed as numbers of molecules of mRNA per ng of total
RNA ± SEM (five independent experiments done in triplicate). ∗p < 0.05.
PFC, prefrontal cortex; MC, motor cortex; STR, striatum; HIP, hippocampus;
DG, dentate gyrus; CB, cerebellum.
FIGURE 5 | Determination of total glutaminase (GA) activity in mouse brain
regions. Significant differences in GA specific activity were found in motor
cortex (WT n = 9; KO n = 5) and PFC (WT n = 12; KO n = 8), but not in
hippocampus (WT n = 16; KO n = 12) and striatum (WT n = 15; KO n = 8).
∗∗∗p < 0.001; ∗p < 0.05.
spine length values evidenced significant differences between
genotypes in this parameter: a clear trend was found towards
longer spines in the KOLPA1 mice (Figure 6I). Then, comparing
lengths between the subtypes of spines (Table 1 below), we
also found significant differences in thin spines between
genotypes. Moreover, quantitative analysis of spine types
(mushroom, thin, stubby or filopodia) indicated drastic
changes in spine populations: filopodia was significantly more
frequent in KO mice in detriment of the mushroom and
stubby categories, which showed marked decreases in the null
LPA1 mice (Figure 6J). In addition, the spine head-width of
mushroom subtype was significant smaller in KOLPA1 spines
(Figure 6L) than in WT (Figure 6K; t-test, ∗∗∗∗p < 0.0001;
Figure 6M).
Therefore, these results strongly suggest that the
formation/maturation of dendritic spines could be significantly
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FIGURE 6 | Golgi-Cox impregnated basal tufts of CA1 pyramidal neurons from WT (A) and KOLPA1 (B) mice. Segments from basal dendrites (stratum oriens, white
rectangles in (A,B) highlight representative dendritic segments) demonstrating the morphological differences between KOLPA1 (F–H) and WT (C–E) spines. Black
arrows point to dendritic filopodia. (I) Overall spine length values showed significant differences between genotypes (WT 1.4 ± 0.05 µm, KOLPA1 2.12 ± 0.09 µm;
Mann-Whitney, ∗∗∗∗p < 0.0001). (J) Significant differences were found in the distribution of dendritic spine morphologies within stratum oriens from KOLPA1 model
compared to the same region of WT mice. Filopodia type was significantly more frequent in KOLPA1 mice in detriment of both mushroom and stubby categories
(t-test, Filopodia ∗∗∗∗p < 0.0001, Stubby ∗∗p = 0.0073 and Thin, n.s.; Mann-Whitney, Mushroom ∗∗∗∗p < 0.0001). (K,L) Spine head of mushroom subtype was
smaller in KOLPA1 (L; L2,L3 depict details from L1 and L4, respectively) than in WT mice (K; K2,K3 depict details from K1 and K4, respectively). (M) Quantitative
analysis demonstrated a significant decrease in the head-width of mushroom spines from KOLPA1 mice (0.52 ± 0.02 µm) compared to WT (0.91 ± 0.02 µm); t-test,
∗∗∗∗p < 0.0001. Scale bar: A,B (10 µm); C–H (2 µm); K1,K4,L1 and L4 (2 µm); K2,K3,L2,L3 (1 µm).
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TABLE 1 | Length (mean ± SEM; µm) of dendritic spine subtypes analyzed from
wild-type (WT) and KOLPA1 mice.
Subtype WT KOLPA1
Mushroom 1.24 ± 0.04 1.26 ± 0.05
Thin∗∗∗ 1.61 ± 0.07 1.95 ± 0.07
Stubby 0.71 ± 0.02 0.65 ± 0.03
Filopodia 4.2 ± 0.3 4.2 ± 0.2
∗∗∗p = 0.0002 (Mann-Whitney).
impaired in the hippocampal pyramidal neurons of KOLPA1
mice.
Silencing of LPA1 Reduces MMP-9, but Not
MMP-2 and tPA Activities
To identify molecular candidates which entrain this structural
change, we investigated alterations in protein expression profiles
of dendritic markers known to be involved in the formation and
modulation of the dendritic spine synapse. Immunoblot analysis
of post-synaptic density protein 95 (PSD95) and synaptophysin
revealed no significant changes in their expression levels between
WT and mutant KOLPA1 mice (results not shown). Matrix
metalloproteinases (MMP) have attracted attention recently as
important modulators of spine morphology, along with other
constitutive proteins well known to be involved in synapsis
formation. Several of these proteins were analyzed in order to
search for altered expression patterns whichmight underlie some
of the changes observed in spine structure. Gelatin zymography
reveals a band at approximately 82 kDa corresponding to
the active form of MMP-9 (Figure 7). Quantitative image
analysis revealed a significant decrease on MMP-9 activity in
cortex (Figure 7A; p = 0.0001) and hippocampus (Figure 7B;
FIGURE 7 | Zymograms of cortical (A) and hippocampal (B) gelatinase activity
from WT and KOLPA1 mice. Matrix metalloproteinase (MMP)-9 and MMP-2
activities were determined in hippocampus and cerebral cortex (whole
hemisphere) from both genotypes (WT n = 8; KO n = 11). Significant
differences were found in MMP-9 proteolytic activity of both brain areas,
showing a decreased activity in KO mice (∗∗∗∗p < 0.0001), while MMP-2
remained unchanged.
p < 0.0001) of KOLPA1 mice. The overall decrease observed
was around a 50% in the LPA1-deficient mice. There was no
change in MMP-2 activity (cortex, p = 0.16; hippocampus,
p = 0.26).
To study the possibility that reduced MMP-9 activity was
due to diminished enzyme expression, Western blot analysis was
performed. Pro-active and active MMP-9 bands were detected
at 92 and 82 kDa, respectively (Figure 8). Quantitative image
analysis of each of the two bands revealed a reduction in active
MMP-9 (Figure 8, cortex, p = 0.03; hippocampus, p = 0.0025) of
KOLPA1 mice. No changes were detected in pro-active MMP-9
brain expression (Figure 8, cortex, p = 0.22; hippocampus,
p = 0.07).
Although tPA/plasmin system has been involved in numerous
aspects of brain function, including dendritic remodeling in
mouse hippocampus (Pawlak et al., 2005) and visual cortex
(Mataga et al., 2004), as well as inducing MMP-9 proteolytic
activation since pro-active form (Wang et al., 2003), we did
not detect any significant changes in tPA activity in cortex
(Figure 9A, p = 0.60) and hippocampus (Figure 9B, p = 0.16)
of KOLPA1 compared with WT mice.
DISCUSSION
LPA1 Deficit Decreases KGA Protein
Expression in Key Glutamatergic Regions
Using affinity-purified isoform-specific antibodies and
immunohistochemistry we revealed a marked deficit of the
most abundant cerebral GA: the KGA isoform encoded by
the Gls gene (Blanco et al., 2012b; Martín-Rufián et al., 2012).
This drastic decrease of KGA protein expression, particularly
relevant in cerebral cortex and hippocampus, was completely
unexpected and cannot be explained by previous experimental
data reporting alterations in the brain of this KO mouse
model. Although a decrease of adult cortical neurons (due
to an increased cortical cell death) was previously described
in KOLPA1 mice (Estivill-Torrús et al., 2008), the reported
lower number of cortical neurons only occurs in layers
II/III, V and VI and seems insufficient to completely justify
the strong reduction found for KGA protein in cerebral
cortex. Similarly, the reduced neurogenesis in the mouse DG
previously noted for KOLPA1 mice (Matas-Rico et al., 2008)
may contribute to part of the deficit shown by KGA in this
subregion, but it does not explain the dramatic silencing
of KGA expression in other hippocampal regions. Despite
the overall fall in KGA protein levels, one striking feature
observed was the intense perivascular mark, which positively
correlated with LPA1 silencing. This gradual shift of KGA
staining toward regions surrounding blood vessels may suggest
a mechanism to control vascular permeability in LPA1-
deficient mice. It is well known that LPA is a critical factor for
regulating angiogenesis in vertebrates (Yukiura et al., 2011),
as well as tight junction permeability in cultured endothelial
cells (Schulze et al., 1997). Therefore, HT and KO animals
may have defects on brain vascular development and/or
blood-brain barrier permeability. Interestingly, glutamate is a
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FIGURE 8 | Immunoblot analysis of MMP-9 protein expression in cerebral cortex (A) and hippocampus (B) from WT and KOLPA1 mice. Quantitive analysis of
proactive (92 kDa) and active (82 kDa) MMP-9 were determined by densitometry and relative to β-actin expression (WT n = 4; KO n = 5). A reduction in active
MMP-9 expression were detected in KOLPA1 compared to WT mice (∗p < 0.05, ∗∗p < 0.01), while no changes were detected in pro-active MMP-9 expression.
vasoactive compound and glutamate receptors are expressed
in perivascular glia and vascular endothelial cells; hence, the
intense vascular KGA reactivity would be a functional response
aimed at regulating the vascular tone under pathophysiological
conditions (reduced or null LPA1 expression). Of note, a role
of GA in cerebrovascular regulation was first postulated by
our group after demonstrating concrete perivascular locations
for brain GA isoforms (Olalla et al., 2008; Márquez et al.,
2009).
Correlation between GLS mRNA abundance, KGA
protein levels and GA activity was only apparent in two
brain regions: prefrontal and motor cortex, which showed
significant decreases at the three levels examined. Mice
lacking LPA1 exhibit motor alterations; thus, reductions in
locomotor activity, hypolocomotion during first exposure
to the open field and reduced exploratory reactivity to a
novel environment have been previously reported (Harrison
et al., 2003; Santin et al., 2009). In contrast, the GLS mRNA
levels in other brain areas, like hippocampus, remained
essentially unaltered; therefore, transcript abundance
did not parallel the behavior shown by KGA protein
levels. This dissociation between transcript and protein
levels for cerebral GA isoforms was previously found
in studies dealing with their involvement in the addictive
behavior of cocaine abuse (Blanco et al., 2012b) or in
neuronal differentiation (Agostini et al., 2016). Hence, the
mechanism(s) underlying the huge decline of KGA protein
levels in brain hippocampus and cerebral cortex regions of
KOLPA1 mice, other than motor and PFC, should be mostly
posttranscriptional.
The maintenance of GA activity in key glutamatergic regions
of KOLPA1 mice, despite substantial decrements in KGA
protein, immediately suggests the existence of compensatory
mechanisms. Accordingly, the glutamate content in PFC and
hippocampus of KOLPA1 mice did not change as compared
with WT mice (Harrison et al., 2003), reinforcing the view
that other GA isozymes may be activated to keep constant
glutamate levels. Although the contribution of each GA isoform
to the pool of neurotransmitter Glu is currently unknown,
KGA is the most abundant GA in mammalian brain (Olalla
et al., 2002; Martín-Rufián et al., 2012) and the principal
source of neurotransmitter glutamate (Márquez et al., 2016
and references therein). Thereby, a plausible explanation is that
neurons attempt to compensate for the loss of KGA protein
by increasing the process of glutamate generation through
other GA isoforms expressed in brain (e.g., enhanced local
activity of GLS2 isozymes). Indeed, two distinct LPA-related
mechanisms are known to enhance the activity of GLS isoforms
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FIGURE 9 | Zymograms of tissue plasminogen activator (tPA) activity in the
cortex (A) and hippocampus (B) of WT and KOLPA1 mice. Quantitative
analysis of tPA activity was determined by densitometry of the 68 kDa band of
substrate degradation (WT n = 4; KO n = 6). No changes in tPA activity were
detected between both type of mice.
and might be operative here via other LPARs distinct from
LPA1. The alternative spliced isoform of KGA, named GAC,
is activated by Rho GTPases (Wang et al., 2010); interestingly,
LPA stimulates activation of Rho in several neuronal cell lines,
cortical progenitors and cortical neurons (Ye et al., 2002). Also,
the Raf-Mek-Erk signaling pathway has been shown to increase
KGA activity by phosphorylation after stimulation by several
mitogens, including LPA (Thangavelu et al., 2012); therefore,
post-translational modifications of the remaining KGA protein
pool would cooperate in keeping basal GA activity in mutant
mice. On the other hand, the existence of compensatory
processes affecting glutamate signaling enzymes and receptors in
KO mouse models has been previously reported. For example,
null mice for the dopamine D4 receptor displayed enhanced
expression of dopamine D1 and glutamate NMDA receptors
(Gan et al., 2004), while mice lacking the mGlu1 receptor
showed a compensatory overexpression of functional mGlu5
(Rossi et al., 2013). Finally, it is worth mentioning that
null mutants mice lacking Gls gene –and therefore without
KGA protein- died in the first postnatal day (Masson et al.,
2006). Nevertheless, the synaptic terminals of Gls−/− neurons
showed apparently normal glutamate content on individual
presynaptic terminals; this unexpected result was explained by
compensatory mechanisms of glutamate synthesis (Masson et al.,
2006).
Role of Glutaminases in Neuronal
Development and Differentiation
Axonal growth, neurite outgrowth and dendrite remodeling
have been described in studies dealing with the role of
LPA in developmental processes of the nervous system
(Fujiwara et al., 2003). Although the post-transcriptional
mechanisms underlying down-regulation of brain KGA after
LPA1 silencing are currently unknown, the shortage in KGA
protein may also give rise to developmental defects in cortical
and hippocampal neurons which, in turn, may contribute
to strong deficits in neurite outgrowth, axon growth and
maturation of dendritic spines. Accordingly, in the KOGLS
mouse model, which shows a slight effect on glutamatergic
synaptic transmission, the authors concluded that KGA deficit
should principally impact the implementation of more active
neural network circuits, stressing the importance of KGA
in neuronal maturation, development and differentiation
(Masson et al., 2006). In fact, KGA has been associated with
neuronal differentiation and proliferation of neural cells.
Thus, both GLS isoforms (KGA and GAC) were upregulated
during neurogenesis of human neural progenitor cells (NPCs),
and their expression pattern positively correlated with the
neuronal marker microtubule associated protein 2 (MAP-2;
Wang et al., 2014). Most important, studies of cultured
human NPCs after siRNA silencing of GLS suggest a critical
role of GLS isoforms for proliferation and survival of NPCs
(Wang et al., 2014). Furthermore, inhibition of GA activity
in cultures of mouse embryonary cortical neurons resulted
in impaired neuritogenesis (Velletri et al., 2013), while both
mRNA and protein KGA levels strongly increased when
cerebellar granule cells differentiate in culture (Thomas et al.,
1989). This last study also demonstrated KGA upregulation in
parallel with Ca2+-dependent glutamate release and formation
of neurites, synaptic vesicles and synapses (Thomas et al.,
1989).
In recent years, the involvement of KGA in the metabolic
reprogramming underlying neuronal differentiation has been
revealed. Thus, during ex vivo differentiation of primary
cortical neurons, the glutamate-glutamine pathway was notably
increased in parallel with upregulation of the GLS and
GLS2 mRNA levels (Agostini et al., 2016). Strikingly, novel
neuronal locations, distinct from mitochondria, were recently
discovered for KGA through interactions with new scaffolding
proteins. Thus, KGA relocalized from neuronal cell body
mitochondria to neurite terminals after interaction with the
protein BNIP-H (Caytaxin), which is highly expressed at the
hippocampus and cerebellum; this specific KGA targeting
occurs in PC12 cells when they differentiated to a neuronal
phenotype, supporting a role in neuronal cell growth (Buschdorf
et al., 2006). A second KGA interacting-partner was later
discovered in brain: Bmcc1s, a protein also involved in the
regulation of cell morphology (Boulay et al., 2013). In mouse
cortical neurons, Bmcc1s interacts with the precursor KGA
protein avoiding its proper targeting to the mitochondria
and leading to its accumulation within the cytoplasm. Thus,
KGA may traffic in neurons to distant sites and is not
exclusively confined to the mitochondria; instead of it,
KGA seems to be needed for neurite outgrowth, dendrites
formation/maturation and establishment of novel synapses.
Therefore, it is tempting to speculate that an impairment
of KGA targeting to synaptic regions, as expected from the
drastic downregulation of KGA shown by KOLPA1 mice, would
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have a negative impact in these mutant mice during brain
development.
Regulation of Dendritic Structure by LPA
It is well documented the role of LPA in synapse formation
through modulation of dendritic spine dynamics. For example,
in cultured hippocampal neurons, the LPA1 receptor was
localized in a punctate manner in dendritic spines and
its overexpression correlated with increases in the density
and size of spines (Pilpel and Segal, 2006). Therefore, we
hypothesized that KOLPA1 mice would display changes in the
morphology of their excitatory synaptic spines. Golgi staining
showed hippocampal dendritic spines with a clear immature
phenotype in KOLPA1 mice: the predominance of filopodia,
in detriment of the mushroom and stubby spines, and the
marked reduction in mushroom spine head-width are relevant
structural changes with potential repercussion in synaptic
neurotransmission. Of note, during the first few weeks of
postnatal life, immature hippocampal dendrites show numerous
filopodia while, in contrast, they are rarely observed in the
mature hippocampus, although blocking synaptic transmission
triggers again filopodia formation (for a review see Bourne and
Harris, 2008).
On the other hand, a considerable body of evidence has
recently shown a key role for MMP-9, and other extracellular
proteases such as tPA, in synaptic remodeling, synaptic plasticity
and cognitive processes (Mataga et al., 2004; Rivera et al.,
2010; Michaluk et al., 2011). In neurons, MMP-9 is located
at the postsynaptic domains of excitatory synapses and its
inhibition has been linked to memory deficits in behavioral
learning paradigms (Nagy et al., 2007). Of note, MMP-9 is a key
regulator of dendritic spine morphology (Michaluk et al., 2011;
Dziembowska and Wlodarczyk, 2012). We therefore examined
the effects of LPA1 depletion on the activity of three extracellular
matrix proteases in hippocampus and cortex: MMP-9, MMP-2
and tPA. Zymography revealed a marked reduction in MMP-9
activity in hippocampus and cortex of KOLPA1 mice compared
with WT counterparts, without significant changes in MMP-2
nor tPA activities.
MMP-9 activation is strictly regulated during spine
maturation (Tian et al., 2007). This inducible MMP is
extracellularly secreted in the pro-active form in which catalytic
site is blocked by a signal peptide. Several factors induce its
activation from pro-active form through the cleavage of the
propeptide. Western blot analysis indicates that brain active
MMP-9 protein expression is reduced in KOLPA1 respect to
WT mice, although there is no significant differences in the
expression of brain pro-active MMP-9. These results indicate
that MMP-9 activity decrement arises due to a decrease in
active MMP-9 processing and release by post-translational
mechanisms. In sharp contrast, no relevant changes were found
for MMP-2 protein in our LPA1-deficient animal models.
Remarkably, in animal models of drug addiction an activation
of MMP-2 occurs after extended withdrawal from drug use:
increases in MMP-2 activity, along with enhanced spine head
diameter and spine number, are persistent neuroadaptations that
occur after chronic drug exposure and underpin the enduring
vulnerability to drug relapse (Mulholland et al., 2016).
The marked reduction of MMP-9 activity in KOLPA1 mice
would prevent transient synaptic plasticity changes needed
for synaptic strength, due to the lack of adequate re-shaping
of spines in hippocampal neurons, thereby having important
functional correlates in the neurophysiological phenotype
of these animals. Interestingly, MMP-9 activity promoted
maturation of dendritic spines and drive spine enlargement
and synaptic potentiation (Wang et al., 2008). Moreover, spines
undergo actin-dependent increases in spine-head volume during
hippocampal long-term potentiation (LTP), whilst the levels
of both the precursor and the active form of MMP-9 are
notably elevated in the CA1 region, suggesting that upregulation
of MMP-9 is related mechanistically to LTP (Huntley, 2012
and references therein). In addition, MMP-9 needs to be
expressed at very high levels in the postnatal hippocampus and
regulation of its expression control neuron numbers (Murase
and McKay, 2012). Thus, the downregulation of MMP-9
activity shown by LPA1 null mice may play an important
role in their cognitive performance: the lack of synaptic
plasticity induced by MMP-9-dependent hippocampal spine
remodeling would partially explain the cognitive and memory
deficits reported in these animals. The reduced MMP-9 activity
would be a downstream effect of the absence of LPA-induced
Rho/Rho kinase (ROCK) signaling pathway, which is known
to produce proteolytic enzymes like MMP-9 (Yu et al., 2014).
Nevertheless, other authors found that spine morphology is
affected by LPA1 independently of its three main signaling
cascades; therefore, they suggest this effect was mostly mediated
by interaction with other synaptic proteins (LPA1 has a
PDZ-binding module at its C-terminal region; Pilpel and Segal,
2006).
CONCLUSION
Our results suggest that LPA1 exerts an important impact
on KGA expression mainly through a posttranscriptional
mechanism, stressing a key relationship between neuroactive
lipids as LPA and glutamatergic transmission. Furthermore, the
absence of LPA1 signaling downregulates expression of active
MMP-9 and provokes drastic changes in hippocampal dendritic
spines toward an immature phenotype. Taken together, these
changes may provide a molecular basis for the role of LPA
in influencing synaptic plasticity associated to cognitive and
memory processes. Further studies are needed to address the
concrete mechanism linking LPA1 signaling and GA expression
in key glutamatergic regions and its relevance for cognitive
function.
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